Evaluating the impact of doxorubicin preconditioning on the efficacy of inhaled recombinant human IL-15 immunotherapy in dogs with pulmonary metastasis
Authors
Daniel York (ORCID: https://orcid.org/0000-0001-6286-2894)
Michael S. Kent (ORCID: https://orcid.org/0000-0002-7703-7720)
School of Veterinary Medicine, University of California, Davis
National Institutes of Health
University of California, Davis
National Cancer Institute
National Center for Advancing Translational Sciences
Center for Companion Animal Health, University of California, Davis
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article
Evaluating the impact of doxorubicin preconditioning on the efficacy of inhaled recombinant human IL-15 immunotherapy in dogs with pulmonary metastasis
Daniel York, Michael S. Kent, Tamar Cohen‐Davidyan, Amandine Lejeune et al.
Citations
1 citations
Journal
Veterinary oncology.
Topics
Immunotherapy and Immune Responses
Field-Weighted Citation Impact (FWCI)
0.80
article
Evaluating the impact of doxorubicin preconditioning on the efficacy of inhaled recombinant human IL-15 immunotherapy in dogs with pulmonary metastasis
Daniel York, Michael S. Kent, Tamar Cohen‐Davidyan, Amandine Lejeune, William J. Murphy, Madison E. Luker, William T. N. Culp, Sita S. Withers, Robert B. Rebhun, Sylvia M. Cruz, Katherine A. Skorupski, Robert J. Canter, Sami Al‐Nadaf, Ellen E. Sparger, Eric G. Johnson, Jacque C. Young
article en
1 citations
Abstract
No abstract available for this paper.
Publication Tag
Veterinary oncology.Vol. 2(1)
Institutions
Veterinary Medical Teaching Hospital (US), The University of Adelaide (AU), University of California, Davis (US)
Funders
School of Veterinary Medicine, University of California, Davis, National Institutes of Health, University of California, Davis, National Cancer Institute, National Center for Advancing Translational Sciences, Center for Companion Animal Health, University of California, Davis